Pharmnxt Biotech Llp - Charges

Every charge - open or closed - that lenders have registered against Pharmnxt Biotech Llp, with the most recent activity at the top.

2017-07-05 Thane, Maharashtra Active LLP
Share
Connect MCP
PB Pharmnxt Biotech Llp
Open charges
4
9.27 cr
Closed charges
1
4.61 cr
Total
5
13.88 cr
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Yes Bank Limited 1 8.40 cr
2 Indusind Bank Ltd. 1 4.61 cr
3 Hdfc Bank Limited 3 87.08 Lakh
All charges (5) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
101124246 Hdfc Bank Limited 06 Jun 2025 - - 17.50 Lakh Open
101124219 Hdfc Bank Limited 28 May 2025 - - 20.99 Lakh Open
101027402 Yes Bank Limited 28 Dec 2024 - - 8.40 cr Open
100632181 Hdfc Bank Limited 31 Mar 2022 - - 48.59 Lakh Open
100447745 Indusind Bank Ltd. 28 Apr 2021 - 27 Feb 2025 4.61 cr Closed
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Pharmnxt Biotech Llp?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Pharmnxt Biotech Llp (CIN: AAJ-9018). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Pharmnxt Biotech Llp.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.